JULIA RO: Open Payments
NPI 1912390428 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,831 in 182 payments from 22 companies in 2025. Trend: 2023 $3,834 · 2024 $4,978 · 2025 $3,831
Food & beverage: $3,741Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $885 |
| Janssen Biotech, Inc. | 14 | $379 |
| UCB, Inc. | 19 | $315 |
| Lilly USA, LLC | 16 | $289 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $253 |
| Arcutis Biotherapeutics, Inc. | 11 | $231 |
| Incyte Corporation | 9 | $190 |
| E.R. Squibb & Sons, L.L.C. | 12 | $187 |
| Galderma Laboratories, L.P. | 8 | $181 |
| LEO Pharma Inc. | 9 | $143 |
Products named: SKYRIZI, RINVOQ, TREMFYA, Bimzelx, Cabtreo, DUPIXENT, TALTZ, Zoryve.
Industry payments across NY — which companies pay providers there.
